High response rates and safe toxic profile of brentuximab vedotin/bendamustine combination in heavily pretreated patients with relapsed/refractory Hodgkin lymphoma (HL) by Wannesson, B., Remaggi, G., Intile, D., Ferrari, L., Cruset, S., Fernández, I., Miodosky, M., Cugliari, M.S., Bordone, J., Pavlovsky, M.A.

Get full text

High response rates and safe toxic profile of brentuximab vedotin/bendamustine combination in heavily pretreated patients with relapsed/refractory H odgkin lymphoma ( HL ) by Wannesson, B., Remaggi, G., Intile, D., Ferrari, L., Cruset, S., Fernández, I., Miodosky, M., Cugliari, M.S., Bordone, J., Pavlovsky, M.A.

Get full text

Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma by Westin, Jason R, Locke, Frederick L, Dickinson, Michael, Ghobadi, Armin, Elsawy, Mahmoud, van Meerten, Tom, Miklos, David B, Ulrickson, Matthew L, Perales, Miguel-Angel, Farooq, Umar, Wannesson, Luciano, Leslie, Lori, Kersten, Marie José, Jacobson, Caron A, Pagel, John M, Wulf, Gerald, Johnston, Patrick, Rapoport, Aaron P, Du, Linqiu, Vardhanabhuti, Saran, Filosto, Simone, Shah, Jina, Snider, Julia T, Cheng, Paul, To, Christina, Oluwole, Olalekan O, Sureda, Anna

Get full text

MA16.01 Subsequent Systemic Therapy After Lurbinectedin Discontinuation in Patients With Small-cell Lung Cancer by Subbiah, V., Paz-Ares, L., Besse, B., Zaman, K., Sala, M.A., Fernández, C., Siguero, M., Kahatt, C., Lopez-Vilariño, J.A., Zeaiter, A., Arrondeau, J., Delord, J., Martínez, M., Wannesson, L., Antón, A., Trigo, J.M.

Get full text

MO01.10 Activity of Lurbinectedin in Second-line SCLC Patients Who Are Candidates for Platinum Rechallenge by Subbiah, V., Paz-Ares, L., Besse, B., Zaman, K., Sala, M.A., López-Vilariño, J.A., Fernández, C., Kahatt, C., Siguero, M., Zeaiter, A., Arrondeau, J., Delord, J.-P., Martínez, M., Antón, A., Trigo, José M., Wannesson, L.

Get full text

S211: CLINICAL AND PATIENT‐REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) VS STANDARD‐OF‐CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL L... by Sureda, A., Westin, J., Locke, F. L., Dickinson, M., Ghobadi, A., Elsawy, M., Meerten, T., Miklos, D. B., Ulrickson, M., Perales, M.‐A., Farooq, U., Wannesson, L., Leslie, L., Kersten, M. J., Jacobson, C. A., Pagel, J. M., Wulf, G., Johnston, P., Rapoport, A. P., Gordon, L. I., Yang, Y., Peng, A., Du, L., Snider, J. T., Shah, J., Schupp, M., Cheng, P., To, C., Oluwole, O. O.

Get full text

P1.12-03 Antitumor Activity of Single Agent Lurbinectedin in Patients with Relapsed SCLC Occurring ≥30 Days After Last Platinum Dose by Trigo Perez, J.M., Subbiah, V., Besse, B., Moreno, V., López, R., Sala, M.a., Ponce, S., Fernendez, C., Nieto, A., Kahatt, C., Zeaiter, A., Zaman, K., Boni, V., Arrondeau, J., Martinez, M., Delord, J., Awada, A., Kristeleit, R., Longo, F., Sarantopoulos, J., Rubio, M., Anton, A., Wannesson, L., Valdivia, J., Shappiro, G., Villalobos, V., Santoro, A., D'Arcangelo, M., Aparicio, L., Paz-Ares, L.

Get full text

A geophysical transect of the Adélie Margin, East Antarctica by Wannesson, Jacques, Pelras, Monique, Petitperrin, Bernard, Perret, Martine, Segoufin, Jacques

Get full text

Lower Cretaceous basalt and sediments from the Kerguelen Plateau by LECLAIRE, L, BASSIAS, Y, WANNESSON, J, DENIS-CLOCCHIATTI, M, DAVIES, H, GAUTIER, I, GENSOUS, B, GIANNESINI, P.-J, PATRIAT, P, SEGOUFIN, J, TESSON, M

Get full text